Advertisement
Screener

GT BIOPHARMA, INC. (GTBP) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

GT BIOPHARMA, INC. Research and Development Expense

GT BIOPHARMA, INC. (GTBP) reported Research and Development Expense of $1.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14

  • GT BIOPHARMA, INC. research and development expense for the quarter ending 2026-06-30 was $1.05M, a 190.63% increase year-over-year.
  • GT BIOPHARMA, INC. research and development expense for the quarter ending 2026-03-31 was $413.00K, a 62.42% decline year-over-year.
  • GT BIOPHARMA, INC. research and development expense for the quarter ending 2025-12-31 was $1.38M, a 28.70% decline year-over-year.
  • GT BIOPHARMA, INC. research and development expense for the quarter ending 2025-09-30 was $634.00K, a 51.49% decline year-over-year.
  • GT BIOPHARMA, INC. research and development expense for fiscal 2025 was $3.47M, a 40.12% decline from fiscal 2024.
  • GT BIOPHARMA, INC. research and development expense for fiscal 2024 was $5.80M, a 10.33% decline from fiscal 2023.
  • GT BIOPHARMA, INC. research and development expense for fiscal 2023 was $6.47M, a 26.61% decline from fiscal 2022.
  • GT BIOPHARMA, INC. research and development expense for fiscal 2022 was $8.81M, a 8.13% decline from fiscal 2021.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2026-06-30$1.05M
10-Q · filed 2026-08-14
$1.47M
10-Q · filed 2026-08-14
$2.84M
derived: sum of 3 quarters · filed 2026-08-14
$3.48M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$413.00K
10-Q · filed 2026-05-15
$1.79M
derived: sum of 2 quarters · filed 2026-05-15
$2.42M
derived: sum of 3 quarters · filed 2026-05-15
$2.79M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$1.38M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02
$2.01M
derived: sum of 2 quarters · filed 2026-03-06
$2.37M
derived: sum of 3 quarters · filed 2026-08-14
$3.47M
10-K · filed 2026-03-02
2025-09-30$634.00K
10-Q/A · filed 2026-03-06
$997.00K
derived: sum of 2 quarters · filed 2026-08-14
$2.10M
10-Q/A · filed 2026-03-06
$4.03M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$363.00K
10-Q · filed 2026-08-14
$1.46M
10-Q · filed 2026-08-14
$3.39M
derived: sum of 3 quarters · filed 2026-08-14
$4.70M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$1.10M
10-Q · filed 2026-05-15
$3.03M
derived: sum of 2 quarters · filed 2026-05-15
$4.34M
derived: sum of 3 quarters · filed 2026-05-15
$6.12M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$1.93M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02
$3.24M
derived: sum of 2 quarters · filed 2026-03-06
$5.02M
derived: sum of 3 quarters · filed 2026-03-06
$5.80M
10-K · filed 2026-03-02
2024-09-30$1.31M
10-Q/A · filed 2026-03-06
$3.09M
derived: sum of 2 quarters · filed 2026-03-06
$3.87M
10-Q/A · filed 2026-03-06
$5.22M
derived: sum of 4 quarters · filed 2026-03-06
2024-06-30$1.78M
10-Q/A · filed 2026-03-06
$2.56M
10-Q/A · filed 2026-03-06
$3.92M
derived: sum of 3 quarters · filed 2026-03-06
$5.28M
derived: sum of 4 quarters · filed 2026-03-06
2024-03-31$777.00K
10-Q · filed 2025-05-15
$2.13M
derived: sum of 2 quarters · filed 2025-05-15
$3.50M
derived: sum of 3 quarters · filed 2025-05-15
$5.59M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$1.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21
$2.72M
derived: sum of 2 quarters · filed 2025-02-21
$4.82M
derived: sum of 3 quarters · filed 2025-02-21
$6.47M
10-K · filed 2025-02-21
2023-09-30$1.36M
10-Q · filed 2024-11-14
$3.46M
derived: sum of 2 quarters · filed 2024-11-14
$5.11M
10-Q · filed 2024-11-14
$7.95M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$2.10M
10-Q · filed 2024-08-14
$3.75M
10-Q · filed 2024-08-14
$6.59M
derived: sum of 3 quarters · filed 2024-08-14
$9.33M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$1.65M
10-Q · filed 2024-05-15
$4.49M
derived: sum of 2 quarters · filed 2024-05-15
$7.24M
derived: sum of 3 quarters · filed 2024-05-15
$8.37M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$2.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26
$5.58M
derived: sum of 2 quarters · filed 2024-03-26
$6.72M
derived: sum of 3 quarters · filed 2024-03-26
$8.81M
10-K · filed 2024-03-26
2022-09-30$2.74M
10-Q · filed 2023-11-01
$3.88M
derived: sum of 2 quarters · filed 2023-11-01
$5.97M
10-Q · filed 2023-11-01
$12.27M
derived: sum of 4 quarters · filed 2023-11-01
2022-06-30$1.14M
10-Q · filed 2023-08-07
$3.23M
10-Q · filed 2023-08-07
$9.53M
derived: sum of 3 quarters · filed 2023-08-07
$10.54M
derived: sum of 4 quarters · filed 2023-08-07
2022-03-31$2.09M
10-Q · filed 2023-05-15
$8.39M
derived: sum of 2 quarters · filed 2023-05-15
$9.40M
derived: sum of 3 quarters · filed 2023-05-15
$10.04M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$6.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$7.31M
derived: sum of 2 quarters · filed 2023-03-30
$7.95M
derived: sum of 3 quarters · filed 2023-03-30
$9.59M
10-K · filed 2023-03-30
2021-09-30$1.01M
10-Q · filed 2022-10-31
$1.65M
derived: sum of 2 quarters · filed 2022-10-31
$3.29M
10-Q · filed 2022-10-31
$3.52M
derived: sum of 4 quarters · filed 2022-10-31
2021-06-30$639.00K
10-Q · filed 2022-08-15
$2.28M
10-Q · filed 2022-08-15
$2.51M
derived: sum of 3 quarters · filed 2022-08-15
$2.60M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$1.64M
10-Q · filed 2022-05-16
$1.87M
derived: sum of 2 quarters · filed 2022-05-16
$1.96M
derived: sum of 3 quarters · filed 2022-05-16
$1.97M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$233.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28
$317.00K
derived: sum of 2 quarters · filed 2022-03-28
$329.00K
derived: sum of 3 quarters · filed 2022-03-28
$485.00K
10-K · filed 2022-03-28
2020-09-30$84.00K
10-Q · filed 2021-11-10
-$84.00K
10-Q · filed 2020-11-13
$96.00K
derived: sum of 2 quarters · filed 2021-12-29
$252.00K
10-Q · filed 2021-11-10
$428.00K
derived: sum of 4 quarters · filed 2021-12-29
2020-06-30$12.00K
10-Q/A · filed 2021-12-29
$336.00K
10-Q/A · filed 2021-12-29
$344.00K
derived: sum of 3 quarters · filed 2021-12-29
$1.01M
derived: sum of 4 quarters · filed 2021-12-29
2020-03-31$324.00K
10-Q · filed 2021-05-17
$332.00K
derived: sum of 2 quarters · filed 2021-05-17
$1.00M
derived: sum of 3 quarters · filed 2021-05-17
$1.16M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$8.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-16
$679.00K
derived: sum of 2 quarters · filed 2021-04-16
$833.00K
derived: sum of 3 quarters · filed 2021-04-16
$1.67M
10-K · filed 2021-04-16
2019-09-30$671.00K
10-Q · filed 2020-11-13
$825.00K
derived: sum of 2 quarters · filed 2020-11-13
$1.66M
10-Q · filed 2020-11-13
$2.89M
derived: sum of 4 quarters · filed 2020-11-13
2019-06-30$154.00K
10-Q/A · filed 2020-08-18
$988.00K
10-Q/A · filed 2020-08-18
$2.22M
derived: sum of 3 quarters · filed 2020-08-18
$3.33M
derived: sum of 4 quarters · filed 2020-08-18
2019-03-31$834.00K
10-Q · filed 2020-05-15
$2.07M
derived: sum of 2 quarters · filed 2020-05-15
$3.18M
derived: sum of 3 quarters · filed 2020-05-15
$6.43M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$1.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27
$2.34M
derived: sum of 2 quarters · filed 2020-03-27
$5.59M
derived: sum of 3 quarters · filed 2020-03-27
$9.07M
10-K · filed 2020-03-27
2018-09-30$1.11M
10-Q · filed 2019-11-14
$4.36M
derived: sum of 2 quarters · filed 2019-11-14
$7.83M
10-Q · filed 2019-11-14
$7.99M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$3.25M
10-Q · filed 2019-08-14
$6.72M
10-Q · filed 2019-08-14
$6.88M
derived: sum of 3 quarters · filed 2019-08-14
$7.41M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$3.47M
10-Q · filed 2019-05-15
$3.63M
derived: sum of 2 quarters · filed 2019-05-15
$4.16M
derived: sum of 3 quarters · filed 2019-05-15
$4.40M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$157.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$683.00K
derived: sum of 2 quarters · filed 2019-03-29
$924.00K
derived: sum of 3 quarters · filed 2019-03-29
$1.07M
10-K · filed 2019-03-29
2017-09-30$526.00K
10-Q · filed 2018-11-14
$767.00K
derived: sum of 2 quarters · filed 2018-11-14
$911.00K
10-Q · filed 2018-11-14
$1.16M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30$241.00K
10-Q · filed 2018-08-14
$385.00K
10-Q · filed 2018-08-14
$635.00K
derived: sum of 3 quarters · filed 2018-08-14
$885.00K
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$144.00K
10-Q · filed 2018-05-15
$394.00K
derived: sum of 2 quarters · filed 2018-05-15
$644.00K
derived: sum of 3 quarters · filed 2018-05-15
$894.00K
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$250.00K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01
$500.00K
derived: sum of 2 quarters · filed 2018-03-01
$750.00K
derived: sum of 3 quarters · filed 2018-03-01
$975.00K
10-K · filed 2018-03-01
2016-09-30$250.00K
10-Q/A · filed 2018-02-28
$500.00K
derived: sum of 2 quarters · filed 2018-02-28
$725.00K
10-Q/A · filed 2018-02-28
$1.25M
derived: sum of 4 quarters · filed 2018-02-28
2016-06-30$250.00K
10-Q/A · filed 2018-02-28
$475.00K
10-Q/A · filed 2018-02-28
$1.00M
derived: sum of 3 quarters · filed 2018-02-28
$1.23M
derived: sum of 4 quarters · filed 2018-02-28
2016-03-31$225.00K
10-Q/A · filed 2018-02-28
$750.00K
derived: sum of 2 quarters · filed 2018-02-28
$975.00K
derived: sum of 3 quarters · filed 2018-02-28
$975.00K
derived: sum of 4 quarters · filed 2018-02-28
2015-12-31$525.00K
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-02-28
$750.00K
derived: sum of 2 quarters · filed 2018-02-28
$750.00K
derived: sum of 3 quarters · filed 2018-02-28
$1.00M
10-K/A · filed 2018-02-28
2015-09-30$225.00K
10-Q/A · filed 2018-02-28
$225.00K
derived: sum of 2 quarters · filed 2018-02-28
$475.00K
10-Q/A · filed 2018-02-28
$475.00K
derived: sum of 4 quarters · filed 2018-02-28
2015-06-30$0.00
10-Q/A · filed 2018-02-28
$250.00K
10-Q/A · filed 2018-02-28
$250.00K
derived: sum of 3 quarters · filed 2018-02-28
$250.00K
derived: sum of 4 quarters · filed 2018-02-28
2015-03-31$250.00K
10-Q/A · filed 2018-02-28
$250.00K
derived: sum of 2 quarters · filed 2018-02-28
$250.00K
derived: sum of 3 quarters · filed 2018-02-28
$250.00K
derived: sum of 4 quarters · filed 2018-02-28
2014-12-31$0.00
derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-28
$0.00
derived: sum of 2 quarters · filed 2018-02-28
$0.00
derived: sum of 3 quarters · filed 2018-02-28
$0.00
10-K/A · filed 2018-02-28
2014-09-30$0.00
10-Q · filed 2015-11-13
$0.00
derived: sum of 2 quarters · filed 2015-11-13
$0.00
10-Q · filed 2015-11-13
$0.00
derived: sum of 4 quarters · filed 2015-11-13
2014-06-30$0.00
10-Q · filed 2015-08-14
$0.00
10-Q · filed 2015-08-14
$0.00
derived: sum of 3 quarters · filed 2015-08-14
$0.00
derived: sum of 4 quarters · filed 2015-08-14
2014-03-31$0.00
10-Q · filed 2015-05-14
$0.00
derived: sum of 2 quarters · filed 2015-05-14
$0.00
derived: sum of 3 quarters · filed 2015-05-14
$0.00
derived: sum of 4 quarters · filed 2015-05-14
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
$0.00
derived: sum of 2 quarters · filed 2015-03-31
$0.00
derived: sum of 3 quarters · filed 2015-03-31
$0.00
10-K · filed 2015-03-31
2013-09-30$0.00
10-Q · filed 2014-12-17
$0.00
derived: sum of 2 quarters · filed 2015-01-08
$0.00
10-Q · filed 2015-01-08
$0.00
derived: sum of 4 quarters · filed 2015-01-08
2013-06-30$0.00
10-Q · filed 2015-01-08
$0.00
10-Q · filed 2015-01-08
$0.00
derived: sum of 3 quarters · filed 2015-01-08
$0.00
derived: sum of 4 quarters · filed 2015-01-08
2013-03-31$0.00
10-Q · filed 2015-01-08
$0.00
derived: sum of 2 quarters · filed 2015-01-08
$0.00
derived: sum of 3 quarters · filed 2015-01-08
$0.00
derived: sum of 4 quarters · filed 2015-01-08
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08
$0.00
derived: sum of 2 quarters · filed 2015-01-08
$0.00
derived: sum of 3 quarters · filed 2015-01-08
$0.00
10-K · filed 2015-01-08
2012-09-30$0.00
10-Q · filed 2014-12-17
$0.00
derived: sum of 2 quarters · filed 2014-12-17
$0.00
10-Q · filed 2014-12-17
-$32.00K
derived: sum of 4 quarters · filed 2014-12-17
2012-06-30$0.00
10-Q · filed 2014-12-12
$0.00
10-Q · filed 2014-12-12
-$32.00K
derived: sum of 3 quarters · filed 2014-12-12
-$32.00K
derived: sum of 4 quarters · filed 2014-12-12
2012-03-31$0.00
10-Q · filed 2014-12-10
-$32.00K
derived: sum of 2 quarters · filed 2014-12-10
-$32.00K
derived: sum of 3 quarters · filed 2014-12-10
-$4.00K
derived: sum of 4 quarters · filed 2014-12-10
2011-12-31-$32.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18
-$32.00K
derived: sum of 2 quarters · filed 2014-11-18
-$4.00K
derived: sum of 3 quarters · filed 2014-11-18
$17.00K
10-K · filed 2014-11-18
2011-09-30$0.00
10-Q · filed 2012-11-21
$28.00K
derived: sum of 2 quarters · filed 2012-11-21
$49.00K
10-Q · filed 2012-11-21
$68.00K
derived: sum of 4 quarters · filed 2012-11-21
2011-06-30$28.00K
10-Q/A · filed 2012-09-13
$49.00K
10-Q/A · filed 2012-09-13
$68.00K
derived: sum of 3 quarters · filed 2012-09-13
$134.00K
derived: sum of 4 quarters · filed 2012-09-13
2011-03-31$21.00K
10-Q · filed 2012-05-21
$40.00K
derived: sum of 2 quarters · filed 2012-05-21
$106.00K
derived: sum of 3 quarters · filed 2012-05-21
$195.00K
derived: sum of 4 quarters · filed 2012-05-21
2010-12-31$19.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16
$85.00K
derived: sum of 2 quarters · filed 2012-04-16
$174.00K
derived: sum of 3 quarters · filed 2012-04-16
$179.00K
10-K · filed 2012-04-16
2010-09-30$66.00K
10-Q · filed 2011-11-21
$155.00K
derived: sum of 2 quarters · filed 2011-11-21
$160.00K
10-Q · filed 2011-11-21
2010-06-30$89.00K
10-Q/A · filed 2011-09-12
$94.00K
10-Q/A · filed 2011-09-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Evommune, Inc. (EVMN)United States$0.320B-5.10
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88